Particle.news

Download on the App Store

Microsoft’s AI Diagnostic Orchestrator Beats Doctors and Cuts Costs

Clinical trials are planned to confirm effectiveness before any consumer integration

Image
Image
Image
Each day, more than 50 million health-related searches are conducted across Microsoft’s AI consumer products, including Copilot, Bing, Edge and MSN. AI's advancements in sequential diagnostics could lead to more helpful, accurate responses, Microsoft AI executives told Newsweek.

Overview

  • MAI-DxO was tested on 304 complex case studies from the New England Journal of Medicine using the Sequential Diagnosis Benchmark.
  • The system achieved 80 percent diagnostic accuracy compared with 20 percent for human physicians under the same test conditions.
  • It reduced diagnostic costs by roughly 20 percent by ordering fewer and less expensive tests.
  • A multi-agent orchestrator queries leading AI models—including OpenAI’s GPT, Google’s Gemini, Anthropic’s Claude, Meta’s Llama and xAI’s Grok—to mimic collaborative clinical reasoning.
  • Microsoft is planning external clinical trials to verify real-world performance and is evaluating potential biases ahead of any consumer integration.